The reviews stress that independent, long-term investigations are essential to inform clinical and public policy decisions and to better establish the role of GLP-1 receptor agonists in long-term weight management
Why GLP-1 weight loss can reveal skin laxity so quickly GLP-1 medications can support meaningful, often rapid weight loss
Tirzepatide generally produces greater weight loss than semaglutide in clinical trials (20.9% vs 14.9% body weight reduction at maximum doses)
When used appropriatelymeaning clinically indicated patients taking FDA-approved formulations prescribed for them per medical guidelines while being monitored by a healthcare professionalthey have a well-characterized safety profile
When you're eating significantly less which many GLP-1 users do, especially in the early weeks protein is what keeps your body from losing muscle mass along with fat
If you have rheumatoid arthritis and are considering compounded GLP-1 therapy for metabolic or weight-related comorbidities, this genetic context can support a deeper conversation with your provider about safety, potential off-label anti-inflammatory effects, and how to monitor disease activity alongside any new treatment
